ASPIrin use and colorectal CANcer risk (ASPICAN)

First published 25/07/2018

Last updated 01/04/2024

EU PAS number:

EUPAS24907

Study

Ongoing

Download as PDF

Documents

Study protocol

Initial protocol

ASPICAN_ENCEPP Protocol_v1

English (111.53 KB - PDF) View document

Study results

No information provided.

Study report

No information provided.

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

No information provided.

ASPIrin use and colorectal CANcer risk (ASPICAN)

Secondary tabs

Share this page